Skip to main content

Intracranial Hypertension in Cystinosis Is a Challenge: Experience in a Children’s Hospital

  • Research Report
  • Chapter
  • First Online:
JIMD Reports, Volume 35

Abstract

Background: Cystinosis is a rare systemic lysosomal disease affecting mainly the kidney and eye. Ocular involvement in cystinosis is universal being the presence of cystine crystals in the cornea a diagnostic criterion and one of the earliest manifestations of the disease. Neuro-ophthalmologic manifestations are considered a rare and late complication in these patients. The aim of this article is to report the unexpectedly high incidence of intracranial hypertension in children with cystinosis at our centre.

Methods: This study included eight children (0–16 years of age) with cystinosis seen at the paediatric ophthalmology department, Hospital Universitari Vall d’Hebron (Barcelona, Spain), a tertiary hospital, over the last 5 years.

Results: Three girls and five boys, mean age: 9.6 years (range: 5–14 years), were studied. During follow-up, 4 out of 8 developed papilledema and confirmed high cerebrospinal fluid (CSF) pressure. The only symptomatic child presented an Arnold–Chiari anomaly with enlarged ventricles, whereas the other three, all asymptomatic, were diagnosed by scheduled fundoscopy and had normal neuroimaging studies. All four patients had at least one known risk factor for developing intracranial hypertension: initiation of growth hormone therapy, tapering of corticosteroids, acute renal failure and Arnold–Chiari malformation. Two of them required a ventriculoperitoneal shunt.

Conclusions: Our results show that intracranial hypertension can occur more frequently than expected in patients with cystinosis. Furthermore, visual prognosis depends on early diagnosis and prompt treatment. A multidisciplinary approach is necessary, and we recommend fundoscopic examinations in all paediatric patients with cystinosis whether or not they present symptoms.

My co-authors have all contributed to this manuscript: planning, conducting and reporting of the work described in the article, and approval of this submission.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CKD:

Chronic kidney disease

CSF:

Cerebrospinal fluid

GFR:

Glomerular filtration rate

ICP:

Increased intracranial pressure

IH:

Intracranial hypertension

LP:

Lumbar puncture

MRI:

Magnetic resonance imaging

MRV:

Magnetic resonance venography

PTCS:

Pseudotumor cerebri syndrome

rhGH:

Recombinant human growth hormone

VA:

Visual acuity

References

  • Besouw MT, Van Dyck M, Francois I et al (2012) Detailed studies of growth hormone secretion in cystinosis patients. Pediatr Nephrol 27:2123–2127

    Article  PubMed  Google Scholar 

  • Blethen SL, Allen DB, Graves D et al (1996) Safety of recombinant deoxyribonucleic acid-derived growth hormone: the national cooperative growth study experience. J Clin Endocrinol Metal 81:1704–1710

    CAS  Google Scholar 

  • Darendeliler F (2009) Safety of growth hormone treatment. J Clin Res Pediatr Endocrinol 1:36–43

    Article  Google Scholar 

  • Dogulu CF, Tsilou E, Rubin B et al (2004) Idiopathic intracranial hypertension in cystinosis. J Pediatr 145:673–678

    Article  PubMed  Google Scholar 

  • Dureau P, Broyer M, Dufier J (2003) Evolution of ocular manifestations in nephropathic cystinosis: a long-term study of a population treated with cysteamine. J Pediatr Ophthalmol Strabismus 40:142–146

    PubMed  Google Scholar 

  • Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81:1159–1165

    Article  PubMed  Google Scholar 

  • Gahl WA, Nesterova G (2010) Cystinosis: the post-transplant era. Eur Nephrol 4:55–61

    Google Scholar 

  • Koller EA, Stadel BV, Malozowski SN (1997) Papilledema in 15 renally compromised patients treated with growth hormone. Pediatr Nephrol 11:451–454

    Article  CAS  PubMed  Google Scholar 

  • Malozowski S, Tanner SA, Wysowski DK et al (1995) Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr 126:996–999

    Article  CAS  PubMed  Google Scholar 

  • Nesterova G, Gahl W (2008) Nephropathic cystinosis: late complications of a multisystemic disease. Pediatr Nephrol 23:863–878

    Article  PubMed  Google Scholar 

  • Nesterova G, Williams C, Bernardini I et al (2015) Cystinosis: renal glomerular and renal tubular function in relation to compliance with cysteine-depleting therapy. Pediatr Nephrol 30:945–951

    Article  PubMed  Google Scholar 

  • Parnes A, Wassner SJ, Weinstein JM (2008) A case of intracranial hypertension and papilledema associated with nephropathic cystinosis and ocular involvement. Binocul Vis Strabismus Q 23:37–40

    PubMed  Google Scholar 

  • PROCYSBI® (cysteamine bitartrate) delayed-release capsules. Label information. Summary of product characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Product_Information/human/002465/WC500151313.pdf. Accessed 22 Jan 2016

  • Rangwala LM, Liu GT (2007) Pediatric idiopathic intracranial hypertension. Surv Ophthalmol 52:597–617

    Article  PubMed  Google Scholar 

  • Rao KI, Hesselink J, Trauner DA (2015) Chiari I malformation in nephropathic cystinosis. J Pediatr 167:1126–1129

    Article  PubMed  PubMed Central  Google Scholar 

  • Reeves GD, Doyle DA (2002) Growth hormone treatment and pseudotumor cerebri: coincidence or close relationship? J Pediatr Endocrinol Metab 15:723–730

    Article  CAS  PubMed  Google Scholar 

  • Richler M, Milot J, Quigley M et al (1991) Ocular manifestations of nephropathic cystinosis: the French-Canadian experience in a genetically homogeneous population. Arch Ophthalmol 109:359–362

    Article  CAS  PubMed  Google Scholar 

  • Rogers AH, Rogers GL, Bremer DL et al (1999) Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology 106:1186–1190

    Article  CAS  PubMed  Google Scholar 

  • Rogers DL, McGregor ML (2010) Increased intracranial pressure in patients with cystinosis. J Pediatr Ophthalmol Strabismus 47:e1–e3

    Article  PubMed  Google Scholar 

  • Ross DL, Strife CF, Towbin R et al (1982) Nonabsorptive hydrocephalus associated with nephropathic cystinosis. Neurology 32:1330–1334

    Article  CAS  PubMed  Google Scholar 

  • Souza FM, Collet-Solberg PF (2011) Adverse effects of growth hormone replacement therapy in children. Arq Bras Endocrinol Metab 55:559–565

    Article  Google Scholar 

  • Touchman JW, Anikster Y, Diatrich NL et al (2000) The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-Kb segment and discovery of a novel gene within the common cystinosis-causing deletion. Genome Res 10:165–173

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tsilou E, Zhou M, Gahl W et al (2007) Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature. Surv Ophthalmol 52:97–105

    Article  PubMed  PubMed Central  Google Scholar 

  • Viltz L, Trauner DA (2013) Effect of age at treatment on cognitive performance in patients with cystinosis. J Pediatr 163:489–492

    Article  PubMed  PubMed Central  Google Scholar 

  • Wühl E, Haffner D, Offner G et al (2001) European Study Group on Growth hormone treatment in children with nephropathic cystinosis: Long-term treatment with growth hormone in short children with nephropathic cystinosis. J Pediatr 138:880–887

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nieves Martín-Begué .

Editor information

Editors and Affiliations

Additional information

Communicated by: Carla E. Hollak, M.D.

Appendices

Take-Home Message

Intracranial hypertension is an unexpected complication in patients with cystinosis and regular fundoscopic examinations are recommended to rule out papilledema.

Compliance with Ethics Guidelines

Conflict of Interest

Nieves Martín-Begué, Silvia Alarcón, Charlotte Wolley-Dod, Luis Enrique Lara, Álvaro Madrid, Paola Cano, Mireia del Toro and Gema Ariceta declare that we have no conflict of interest.

Informed Consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in this study. Additional informed consent was obtained from all patients (or from their parents) for which identifying information is included in this article.

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Society for the Study of Inborn Errors of Metabolism (SSIEM)

About this chapter

Cite this chapter

Martín-Begué, N. et al. (2016). Intracranial Hypertension in Cystinosis Is a Challenge: Experience in a Children’s Hospital. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 35. JIMD Reports, vol 35. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2016_18

Download citation

  • DOI: https://doi.org/10.1007/8904_2016_18

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-55832-4

  • Online ISBN: 978-3-662-55833-1

  • eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)

Publish with us

Policies and ethics